Product Information

DESVENLAFAXINE SUCCNT ER 100 MG is a generic product labeled by Slate Run Pharmaceuticals LLC, priced at $0.4069 per EA under NDC 70436001306. Its NADAC has been published 297 times since Dec 16, 2020.

FDA first approved this application on Oct 1, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

DESVENLAFAXINE SUCCNT ER 100 MG

Desvenlafaxine
$0.4069per EA

Strength

100 mg/1

NDC

70436001306

Classification

Generic

Dosage Form

TABLET, EXTENDED RELEASE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

DESVENLAFAXINE SUCCINATE

Approval Type

Generic (ANDA)

FDA Application

ANDA210014

FDA Approved

10/1/2018

TE Code

AB

On Market Since

8/1/2020

Pharmacological Classes

Cytochrome P450 2D6 Inhibitors
Norepinephrine Uptake Inhibitors
Serotonin Uptake Inhibitors
Serotonin and Norepinephrine Reuptake Inhibitor

Price Statistics

The NADAC for DESVENLAFAXINE SUCCNT ER 100 MG has been published 297 times since Dec 16, 2020, and over the history we have for it it has declined 41.6%. The table below summarizes its recorded NADAC range and movement.

Current price$0.4069 per EA
All-time high$0.7075 (Mar 10, 2021)
All-time low$0.3558 (Nov 20, 2024)
52-week high$0.4587
52-week low$0.4069
Median price$0.5124
Average price$0.5229
Largest weekly change+25.7% (Jun 19, 2024)
Weeks tracked297
Tracking sinceDec 16, 2020

Price History

1W

-2.5%

1M

-2.5%

3M

-4.6%

6M

-5.8%

1Y

-11.3%

3Y

-19.8%

5Y

-37.6%

All

-41.6%

Generic Alternatives

The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of DESVENLAFAXINE SUCCNT ER 100 MG?

The current National Average Drug Acquisition Cost (NADAC) for DESVENLAFAXINE SUCCNT ER 100 MG, manufactured by Slate Run Pharmaceuticals LLC, is $0.4069 per EA (NDC 70436001306), effective Aug 19, 2026.

How has the price of DESVENLAFAXINE SUCCNT ER 100 MG changed over time?

Over the history we have for it, the NADAC for DESVENLAFAXINE SUCCNT ER 100 MG has declined 41.6%. It has been tracked across 297 weekly CMS publications since Dec 16, 2020.

What are the highest and lowest recorded NADAC prices for DESVENLAFAXINE SUCCNT ER 100 MG?

Since Dec 16, 2020, the NADAC for DESVENLAFAXINE SUCCNT ER 100 MG has ranged from a low of $0.3558 (Nov 20, 2024) to a high of $0.7075 (Mar 10, 2021), with a median of $0.5124 per EA.

Are there cheaper alternatives to DESVENLAFAXINE SUCCNT ER 100 MG?

4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as DESVENLAFAXINE SUCCNT ER 100 MG in a comparable dosage form, but none are currently priced below it.

Who manufactures DESVENLAFAXINE SUCCNT ER 100 MG?

DESVENLAFAXINE SUCCNT ER 100 MG (NDC 70436001306) is labeled by Slate Run Pharmaceuticals LLC, and CMS classifies it as a generic product.